+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Auto Transfusion Devices Market - Forecasts from 2025 to 2030

  • PDF Icon

    Report

  • 145 Pages
  • November 2025
  • Region: Global
  • Knowledge Sourcing Intelligence LLP
  • ID: 6099674
The Auto Transfusion Devices Market is set to increase from USD 622.250 million in 2025 to USD 833.890 million by 2030, registering a 6.03% CAGR.

The autotransfusion devices market is experiencing significant growth, driven by the rising global prevalence of cardiovascular diseases, which, according to the World Health Organization, account for approximately 17.9 million deaths annually, or 31% of global mortality. These devices, used to collect and reinfuse a patient’s own blood during surgical procedures, are increasingly adopted due to their ability to reduce the risk of infectious disease transmission and eliminate isosensitization risks. Additionally, growing healthcare investments in developing countries bolster market expansion by enhancing access to advanced medical technologies.

This research examines current trends in demand, supply, and sales, alongside recent developments shaping the autotransfusion devices market. It provides a comprehensive analysis of key drivers, restraints, and opportunities. The study details industry trends, policies, and regulations across geographical regions, offering stakeholders a thorough understanding of the regulatory framework and critical factors influencing the market environment.

Competitive intelligence identifies major industry players and their revenue contributions, derived from extensive secondary research. Sources include industry association studies, analyst reports, investor presentations, press releases, and journals. Market size for the overall autotransfusion devices sector and its key segments was determined using both bottom-up and top-down methodologies. Values were validated with primary inputs from stakeholders in the global autotransfusion devices value chain. Comprehensive market engineering integrated data from diverse sources and proprietary datasets, employing data triangulation for accurate market breakdown and forecasting.

Market insights are presented through analytical narratives, charts, and graphics, enabling efficient comprehension of global autotransfusion devices market dynamics. The report explores demand across various device types and technologies, including intraoperative, postoperative, and emergency autotransfusion systems, as well as applications in hospitals, ambulatory surgical centers, and specialty clinics. It also investigates technological advancements, government policies, regulatory frameworks, and macroeconomic factors.

This report equips industry experts with critical insights into market trends, regulatory landscapes, and competitive dynamics. It highlights growth opportunities driven by the increasing burden of cardiovascular diseases and healthcare infrastructure investments, particularly in developing regions. The rigorous methodology, blending primary and secondary data, ensures reliable findings, enabling stakeholders to navigate regulatory complexities, competitive pressures, and investment priorities in a market vital to improving surgical outcomes and patient safety through innovative blood management solutions.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, and Competitive Intelligence.

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Segmentation

  • By Type
    • Intraoperative
    • Postoperative
  • By Application
    • Cardiovascular Surgery
    • Orthopedic Surgery
    • Neurology Surgery
    • Organ Transplantation
    • Others
  • By End-User Industry
    • Hospitals
    • Ambulatory Surgery Centres
    • Others
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • United Kingdom
      • Germany
      • France
      • Italy
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Others
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Taiwan
      • Thailand
      • Indonesia
      • Others

Table of Contents

1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. AUTO TRANSFUSION DEVICES MARKET BY TYPE
5.1. Introduction
5.2. Interoperative
5.3. Postoperative
5. AUTO TRANSFUSION DEVICES MARKET BY APPLICATION
5.1. Introduction
5.2. Cardiovascular Surgery
5.3. Orthopedic Surgery
5.4. Neurology Surgery
5.5. Organ Transplantation
5.5. Others
7. AUTO TRANSFUSION DEVICES MARKET BY END-USER INDUSTRY
7.1. Introduction
7.2. Hospitals
7.3. Ambulatory Surgery Centres
7.4. Others
8. AUTO TRANSFUSION DEVICES MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia-Pacific
8.6.1. China
8.6.2. Japan
8.6.3. India
8.6.4. South Korea
8.6.5. Taiwan
8.6.6. Thailand
8.6.7. Indosneisa
8.6.8. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Medline Industries, LP
10.2. Medtronic plc
10.3. Haemonetics Corporation
10.4. Fresenius Kabi AG
10.5. Terumo Corporation
10.6. LivaNova
10.7. Atrium Medical
10.8. BD
10.9. Stryker Corporation
10.10. Zimmer Biomet Holdings, Inc.
11. RESEARCH METHODOLOGYLIST OF FIGURESLIST OF TABLES

Companies Mentioned

  • Medline Industries, LP
  • Medtronic plc
  • Haemonetics Corporation
  • Fresenius Kabi AG
  • Terumo Corporation
  • LivaNova
  • Atrium Medical
  • BD
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.

Table Information